Kerin L. Tyrrell
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 13
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 40
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 28
- Clostridium difficile and Clostridium perfringens research 19
- Microbiology top 2%
-
- Streptococcal Infections and Treatments 27
-
- Antibiotics Pharmacokinetics and Efficacy 15
-
- Rabies epidemiology and control 11
-
- Pneumonia and Respiratory Infections 7
- Co-authors
- Diane M. CitronEllie J. C. GoldsteinC. Vreni MerriamYumi A. WarrenHelen T. FernandezPaul A. LawsonSydney M. FinegoldMarina C. Claros
- Journals
- SHILAP Revista de lepidopterología (1 paper)Clinical Infectious Diseases (2 papers)Journal of Clinical Microbiology (5 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Kerin L. Tyrrell
82 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Molecular Medicine 472
- Clinical Biochemistry 608
- Applied Microbiology and Biotechnology 168
- Infectious Diseases 1.3k
- Microbiology 199
Countries citing papers authored by Kerin L. Tyrrell
This map shows the geographic impact of Kerin L. Tyrrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerin L. Tyrrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerin L. Tyrrell more than expected).
Fields of papers citing papers by Kerin L. Tyrrell
This network shows the impact of papers produced by Kerin L. Tyrrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerin L. Tyrrell. The network helps show where Kerin L. Tyrrell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kerin L. Tyrrell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 1 | |
| 2 | 2018 | 3 | |
| 3 | 2018 | 21 | |
| 4 | 2017 | 4 | |
| 5 | Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O’Toole 1935) Prévot 1938breakdown → | 2016 | 399 |
| 6 | 2016 | 11 | |
| 7 | 2014 | 37 | |
| 8 | 2013 | 22 | |
| 9 | 2013 | 14 | |
| 10 | 2013 | 22 | |
| 11 | 2011 | 32 | |
| 12 | 2011 | 20 | |
| 13 | 2007 | 7 | |
| 14 | 2006 | 24 | |
| 15 | 2006 | 14 | |
| 16 | 2005 | 14 | |
| 17 | 2005 | 23 | |
| 18 | 2003 | 38 | |
| 19 | 2003 | 21 | |
| 20 | 2002 | 27 |
About Kerin L. Tyrrell
Kerin L. Tyrrell is a scholar working on Clinical Biochemistry, Molecular Medicine and Infectious Diseases, having authored 82 papers that have together received 2.9k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (40 papers), Antimicrobial Resistance in Staphylococcus (28 papers), Streptococcal Infections and Treatments (27 papers), Clostridium difficile and Clostridium perfringens research (19 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers), Antibiotic Resistance in Bacteria (13 papers), Rabies epidemiology and control (11 papers) and Pneumonia and Respiratory Infections (7 papers). The work is most often cited by research in Molecular Medicine (472 citations), Clinical Biochemistry (608 citations) and Applied Microbiology and Biotechnology (168 citations). Kerin L. Tyrrell has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Diane M. Citron, Ellie J. C. Goldstein, C. Vreni Merriam, Yumi A. Warren, Helen T. Fernandez, Paul A. Lawson, Sydney M. Finegold, Marina C. Claros, Georg Conrads and Jeffrey R. Jenkins. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.